Heart Failure
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Hospitalized patients with heart failure aged > 18 years; Voluntarily participate in this study; Diagnosis of heart failure in accordance with National Heart Failure Guidelines 2023
Exclusion criteria
Exclusion criteria: 1. Assess physical conditions unsuitable for wearing a ReDS non-invasive pulmonometer, including but not limited to: BMI39kg/m2, or height 195cm, or flail chest, etc. (ReDS should be tested for patients with a BMI of 20-22kg/m^2, and patients with a height of 150-155cm to ensure physical fitness); 2. Have a history of heart transplantation or left ventricular assist device implantation, and are still implanted; 3. Combined pulmonary disease, such as active pneumonia, acute pulmonary embolism, or history of acute pulmonary embolism within the past 6 months; 4. Severe pulmonary hypertension caused by non-left heart disease (pulmonary systolic blood pressure =70mmHg as measured by echocardiography); 5. Simple right heart failure; 6. Patients who have undergone open-heart surgery or other operations or procedures during or within one year of their intended hospitalization that affect the wearing of ReDS; 7. Pulmonary tissue insufficiency due to various reasons such as surgery and trauma; 8. Patients with severe renal insufficiency (eGFR<20ml/min/1.73m^2) or dialysis; 9. Complicated with malignant tumor or other serious diseases, and the expected survival time is less than 1 year; 10. Women in pregnancy, pregnancy is defined as the state of a woman after pregnancy until termination of pregnancy; 11. Failure to follow study instructions or to follow examination, evaluation and follow-up procedures; 12. Any other medical condition that the investigator believes may put the patient at risk or affect the results of the study, or that the investigator believes there is a medical condition that is not appropriate for the study; 13. Participating in other intervention studies (including patients during washout)
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Chest X-ray;NT-proBNP;PCWP;HCT;Urine specific gravity;IVCD;Ultrasound extravascular lung fluid;CVP; | — |
Primary
| Measure | Time frame |
|---|---|
| Noninvasive lung fluid value ReDS; | — |
Countries
China
Contacts
Fuwai Hospital, Chinese Academy of Medical Sciences